小鼠单克隆抗体[5a-8] to CD90 / Thy1
ab112209 reacts with all Tlymphocytes from Mouse strains expressing the CD90 / Thy1 phenotype (eg. C57BL/6, C3H/He ,DBA/2, CBA/J, BALB/c), but does react with lymophocytes expressing the Thy 1.1 phenotype [eg. AKR/J, B6.PL (74NS)].
CD90/ Thy1 from AKR/J spleen.
Lyophilised:Reconstitute with 1.0 ml of cold distilled water.
Shipped at 4°C. After reconstitution store at -20ºC. Avoid freeze / thaw cycles.
Constituent: 100% Tissue culture supernatant
Concentration information loading...
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/20 - 1/40. (in 1 x 10
6-7 cells per ml).
May play a role in cell-cell or cell-ligand interactions during synaptogenesis and other events in the brain.
Contains 1 Ig-like V-type (immunoglobulin-like) domain.
Information by UniProt
CD90 antigen antibody
Functional Studies - CD90 / Thy1 antibody [5a-8] (ab112209)
Antibody Titration by Cytotoxicity Analysis:
Cell source: Thymus
Cell concentration: 1.1 x 10
Complement: from Rabbit
Complement concentration: 1/22.
Tissue Distribution by Cytotoxicity Analysis:
ab112209 concentration used: 1/40
Cell source: Cytotoxity Index
Lymph node: 69
Bone marrow: 3
Strain Distribution by Cytotoxicity Analysis:
ab112209 concentration used: 1/20
Strains tested: AKR/J, C57BL/6, BALB/c, C3H/He, ATH,CBA/J
Positive: C57BL/6, BALB/c, C3H/He, ATH, CBA/J
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"